Biochemical effects of consumption of eggs containing omega-3 polyunsaturated fatty acids

References

• Watkins LO (2004). Epidemiology and burden of cardiovascular disease. Clin Cardiol 27: 2–6.
   Web of Science ®Google Scholar
• Hu FB, Willett WC (2002). Optimal diets for prevention of coronary heart disease. JAMA 288: 2569–78.
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP (1999). The spread of the obesity epidemic in the United States, 1991–1998. JAMA 282: 1519–22.
   Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–53.
   Google Scholar
• Hu FB, Manson JE, Willett WC (2001). Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 20: 5–19.
   PubMed Web of Science ®Google Scholar
• Mehra VC, Ramgolam VS, Bender JR (2005). Cytokines and cardiovascular disease. J Leukoc Biol 78: 805–18.
   PubMed Web of Science ®Google Scholar
• Drevon CA (2005). Fatty acids and expression of adipokines. Biochim Biophys Acta 1740: 287–92.
   PubMed Web of Science ®Google Scholar
• Zwaka TP, Hombach V, Torzewski J (2001). C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103: 1194–7.
   PubMed Web of Science ®Google Scholar
• Ballantyne CM, Andrews TC, Hsia JA, Kramer JH, Shear C, ACCESS Study Group (2001). Ator-vastatin Comparative Cholesterol Efficacy and Safety Study. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels. Am J Cardiol 88: 265–9.
   Google Scholar
• Crouse JR 3rd, Frohlich J, Ose L, Mercuri M, Tobert JA (1999). Effects of high doses of sim-vastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiol 83: 1476–7.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al (2001). Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344: 1959–65.
   Web of Science ®Google Scholar
• McNamara DJ (1999). Eggs, dietary cholesterol and hart disease risk: an international perspec-tive. In Egg nutrition and biotechnology. Edited by Sim JS, Nakai S and Guenter W. New York: CABI Publishing; 55–64.
   Google Scholar
• Farrell DJ (1998). Enrichment of hen eggs with n-3 long-chain fatty acids and evaluation of en-riched eggs in humans. Am J Clin Nutr 68: 538–44.
   PubMed Web of Science ®Google Scholar
• Food and Agriculture Organization of the United Nations (1970). The Amino Acid Content of Foods and Biological Data on Proteins. Nutritional Study #24. Rome.
   Google Scholar
• Dennis MS, Lewis SC, Warlow C, FOOD Trial Collaboration (2005). Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365: 764–72.
   PubMed Web of Science ®Google Scholar
• Baldwin C, Parsons T, Logan S (2001). Dietary advice for illness-related malnutrition in adults. Cochrane Database Syst Rev 2: CD002008.
   Google Scholar
• Hagfors L, Nilsson I, Sköldstam L, Johansson G (2005). Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr Metab 2: 26.
   Google Scholar
• Farrell DJ (1999). Not all co-3 enriched eggs are the same. In Egg nutrition and biotechnology. Edited by Sim JS, Nakai S and Guenter W. New York: CABI Publishing; 151–62.
   Google Scholar
• Kris-Etherton P, Yu S (1997). Individual fatty acids on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 65: 1628–44.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001). High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358: 2026–33.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner 1(2004). Apolipoprotein B and apolipoprotein A-I: risk indicators of coro-nary heart disease and targets for lipid-modifying therapy. J Intern Med 255: 188–205.
   PubMed Web of Science ®Google Scholar
• Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, et al (2003). Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lan-cet 361: 777–80.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner 1(2005). Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26: 210–2.
   PubMed Web of Science ®Google Scholar
• Stewart BF, Brown BG, Zhao XQ, Hillger LA, Sniderman AD, Dowdy A, et al (1994). Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confmed to those with very high low density lipoprotein cholesterol. J Am Coll Cardiol 23: 899–906.
   PubMed Web of Science ®Google Scholar
• Ghafoorunissa, Ibrahim A, Natarajan S (2005). Substituting dietary linoleic acid with alpha-lino-lenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta 1733: 67–75.
   Google Scholar
• Nettleton JA, Katz R (2005). n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105: 428–40.
   PubMed Web of Science ®Google Scholar